Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7.29 Billion | USD 13.04 Billion | 6.68% | 2023 |
The global Cardiac Arrhythmia Monitoring Devices market size was worth around USD 7.29 billion in 2023 and is predicted to grow to around USD 13.04 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.68% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Cardiac Arrhythmia Monitoring Devices market on a global and regional level.
Cardiac Arrhythmia can be described as a collection of conditions in which the heartbeat is irregular. Cardiac Arrhythmia or irregular heartbeat can be divided into bradycardia (slow heartbeat), tachycardia (fast heartbeat), premature contraction (early heartbeat), and fibrillation (irregular heartbeat). Multiple factors can lead to arrhythmias like diabetes, alcohol abuse, heart disorders, and hypertension among other things. Cardiac monitoring is carried out to identify heart rhythm diseases.
Factors such as technological advancements in cardiac arrhythmia monitoring devices, increasing incidence of cardiovascular disorders, growing preference for low-cost ECG devices, and healthcare cost containment will act as major driving factors in the growth of the global cardiac arrhythmia monitoring devices market. Favorable government policies worldwide, and increasing healthcare spending in developing regions will act as an opportunity for the market players in the cardiac arrhythmia monitoring devices market. Nonetheless, product recalls, high costs,s and lack of awareness in low-income countries will restrict the growth of the global cardiac arrhythmia monitoring devices market.
In order to give the users of this report a comprehensive view of the cardiac arrhythmia monitoring devices market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product and services segment is benchmarked based on their market size, growth rate, and general attractiveness.
The report provides a company market share analysis in order to give a broader overview of the key players in the cardiac arrhythmia monitoring devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the cardiac arrhythmia monitoring devices market on a global and regional basis.Request Free Sample
The global cardiac arrhythmia monitoring devices market has been split into device, application, end user, and region.
Based on the device, the cardiac arrhythmia monitoring devices market has been segmented into event recorders, electrocardiogram monitors, Holter monitors, implantable cardiac monitors, and mobile cardiac telemetry. The Holter monitor segment accounted for the highest market share in 2023 due to the increasing adoption of such monitors amongst aging people.
The application segment has been segmented into premature contraction, bradycardia, and tachycardia. The tachycardia segment accounted for the highest market share in 2023 due to a rise in the occurrence of heart ailments such as flutter and atrial fibrillation.
The end user segment has been segmented into diagnostic centers, hospitals and clinics, home care settings, and ASCs.
Report Attributes | Report Details |
---|---|
Report Name | Cardiac Arrhythmia Monitoring Devices Market |
Market Size in 2023 | USD 7.29 Billion |
Market Forecast in 2032 | USD 13.04 Billion |
Growth Rate | CAGR of 6.68% |
Number of Pages | 110 |
Key Companies Covered | Aurora Resurgence, GE Healthcare, Applied Cardiac Systems, Biotronik, AliveCor, Biotricity, BioTelemetry, Koninklijke Philips N.V., iRhythm Technologies, St. Jude Medical (Abbott Laboratories), Medtronic plc, Spacelabs Healthcare, and Nihon Kohden Corporation among others |
Segments Covered | By Device, By End User, By Application and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America will be the leading region during the forecast period. The presence of prominent market players, FDA approvals, and rapid acceptance of new technologies will boost market growth in this region. Europe will be the second largest market. The major reasons are a rise in awareness regarding the use of cardiac monitoring devices, a high prevalence of cardiovascular disorders, and favorable reimbursement scenarios. The Asia Pacific will propagate at a speedy rate over the forecast period due to fast technological updation in the healthcare division and growing cases of cardiovascular disorders. The Latin American market will develop at a significant rate during the forecast period. The African and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.
The report also includes detailed profiles of key players such as:
Global Cardiac Arrhythmia Monitoring Devices Market: By Device
Global Cardiac Arrhythmia Monitoring Devices Market: By End User
Global Cardiac Arrhythmia Monitoring Devices Market: By End User
Global Cardiac Arrhythmia Monitoring Devices Market: By Region
FrequentlyAsked Questions
Cardiac arrhythmia monitoring devices are used to detect, diagnose, and manage irregular heart rhythms (arrhythmias).
According to study, the Cardiac Arrhythmia Monitoring Devices Market size was worth around USD 7.29 billion in 2023 and is predicted to grow to around USD 13.04 billion by 2032.
The CAGR value of Cardiac Arrhythmia Monitoring Devices Market is expected to be around 6.68% during 2024-2032.
North America has been leading the Cardiac Arrhythmia Monitoring Devices Market and is anticipated to continue on the dominant position in the years to come.
The Cardiac Arrhythmia Monitoring Devices Market is led by players like Aurora Resurgence, GE Healthcare, Applied Cardiac Systems, Biotronik, AliveCor, Biotricity, BioTelemetry, Koninklijke Philips N.V., iRhythm Technologies, St. Jude Medical (Abbott Laboratories), Medtronic plc, Spacelabs Healthcare, Nihon Kohden Corporation, and among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed